ClearSight Highlights the Proven Safety and High Success of SMILE Eye Surgery in New Article

Oklahoma City, Oklahoma -

ClearSight LASIK & Lens, a leading provider of advanced vision correction solutions, has released an in-depth article exploring the safety and effectiveness of SMILE (Small Incision Lenticule Extraction) eye surgery, a revolutionary laser vision correction procedure for nearsightedness and astigmatism. With millions of SMILE surgeries performed globally, the article addresses the concerns of potential patients and showcases why SMILE is becoming an increasingly popular choice for vision correction over traditional LASIK surgery. The article, titled “Is SMILE Eye Surgery Proven and Safe?” can be found on ClearSight’s website here: https://www.clearsight.com/smile/is-smile-eye-surgery-proven-and-safe/

SMILE is a minimally invasive, FDA-approved procedure that offers significant benefits, particularly for those with nearsightedness who seek freedom from glasses or contacts. Unlike LASIK, SMILE doesn’t require the creation of a corneal flap. Instead, the procedure involves creating a small incision, typically 2-4 mm in length, to extract a lenticule (a thin disc of tissue) from within the cornea. This technique minimizes disruption to the corneal structure, which helps preserve corneal integrity, reduces the risk of dry eye, and offers faster healing times. This advanced approach to vision correction not only makes SMILE a safe option but also one with a very high satisfaction rate among patients.

With a success rate comparable to or even exceeding LASIK in some cases, SMILE offers excellent visual outcomes. Studies show that around 85-90% of SMILE patients achieve 20/20 vision or better within six months post-surgery, with most reaching their visual goals even sooner. Long-term research further underscores SMILE's effectiveness, with 97% of patients achieving 20/25 vision or better five years after surgery. This consistency makes SMILE one of the most reliable choices for those seeking lasting, clear vision without the use of corrective lenses. ClearSight’s own patient results have been superior to this given the optimization of laser settings that they have diligently worked on for years. ClearSight is so confident in the results that it offers a "20/20 or it’s free" guarantee, underscoring the clinic’s commitment to patient success.

Safety is at the core of ClearSight’s mission, and SMILE has repeatedly demonstrated its commitment to that standard. Globally, SMILE has been performed over 10 million times since its commercial introduction in 2011 and its FDA approval in 2016. The procedure’s minimally invasive nature means there’s no need for a flap in the cornea, a defining feature that sets it apart from LASIK. This small but crucial difference leads to fewer flap-related complications and reduced chances of dry eye syndrome. SMILE has shown to cause fewer higher-order aberrations, which can improve clarity and sharpness in visual perception, ultimately enhancing patients' overall satisfaction with the results.

In addition to its high success rate, SMILE eye surgery boasts a low rate of complications, which is another reason many patients prefer it over other options. The procedure has shown a low incidence of complications such as infection, glare, and halos. Patients typically experience less discomfort during and after the procedure and report faster recovery times. Most are able to return to normal daily activities within 24 hours of surgery, which is especially appealing for individuals with active lifestyles or demanding careers. Patients report that SMILE’s quick recovery time, paired with reduced discomfort, makes the procedure feel more convenient and manageable than other vision correction options.

ClearSight’s article also highlights SMILE’s suitability for those who do not want a corneal flap. SMILE does not rely on a corneal flap, which makes it an attractive choice for those whose corneal structure would benefit from the procedure’s minimally invasive approach. This careful preservation of the cornea’s natural biomechanics not only potentially enhances structural stability but may also reduce the potential risk of future complications like corneal ectasia, a condition where the cornea weakens over time.

ClearSight’s medical team also discusses why SMILE may lead to fewer post-surgery complications than other refractive surgeries. The smaller incision of SMILE preserves more corneal nerves, which translates to a lower risk of dry eye symptoms. Many SMILE patients find that they experience less dryness compared to LASIK patients, allowing them to feel comfortable and confident in their vision soon after surgery.

As more patients explore vision correction options, ClearSight emphasizes that every potential candidate should undergo a thorough eye health evaluation to determine which procedure is right for them. ClearSight’s team is committed to individualized care, utilizing advanced diagnostic tools to ensure that each patient receives the most appropriate treatment for their unique vision needs. For those interested in SMILE, this involves a detailed analysis of factors such as corneal thickness, refractive error, and overall eye health. The article clarifies that while SMILE is generally safe for individuals with nearsightedness and astigmatism, an eye examination is necessary to confirm suitability.

ClearSight’s publication comes at a critical time when the demand for effective, safe, and minimally invasive vision correction is on the rise. With a high success rate, quick recovery time, and low complication risk, SMILE represents an innovative solution to age-old vision problems. Potential patients and interested readers are encouraged to visit ClearSight’s website to read the full article and discover how SMILE can be the key to achieving their vision goals. This article not only explains the proven safety and efficacy of SMILE but also provides valuable insight into ClearSight’s commitment to patient satisfaction and well-being.

For more information about ClearSight and SMILE eye surgery, or to schedule an interview with ClearSight’s specialists, please contact ClearSight Media Relations.